Recorded Chinese product: 莲必治注射液莲必治注射液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 神威药业集团有限公司Chinese legal name: 神威药业集团有限公司
主要成分Active Ingredients
- 亚氢钠穿心莲内酯Yaqing Nachuan Xinlian Neizhi
药物知识说明
亚氢钠穿心莲内酯是一种在国家药监局注册认定的药品。标注生产企业为神威药业集团有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：神威药业集团有限公司Chinese legal name: 神威药业集团有限公司、神威药业集团有限公司Chinese legal name: 神威药业集团有限公司、神威药业集团有限公司Chinese legal name: 神威药业集团有限公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 莲必治注射液) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 神威药业集团有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 神威药业集团有限公司Chinese legal name: 神威药业集团有限公司, 神威药业集团有限公司Chinese legal name: 神威药业集团有限公司, 神威药业集团有限公司Chinese legal name: 神威药业集团有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 莲必治注射液Recorded Chinese product: 莲必治注射液
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 每支装10ml10 mL per unit
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 神威药业集团有限公司Chinese legal name: 神威药业集团有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字Z13020788
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字Z13020788
Manufacturer
Chinese legal name: 神威药业集团有限公司 (domestically manufactured)
Traditional functions
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字Z13020788
生产企业
神威药业集团有限公司(国产)
功能主治
清热解毒，抗菌消炎。用于细菌性痢疾，肺炎，急性扁桃体炎。
用法用量
1.肌内注射，一次0.1～0.2g，一日2次。 2.静脉滴注，一日0.4～0.75g，加于5%葡萄糖注射液或氯化钠注射液中滴注。
不良反应
本品有引起急性肾功能损害的风险。除急性肾功能损害外，发现的不良反应还有皮疹、头晕、胃肠道反应、过敏样反应等。
禁忌
对本品有过敏者禁用；高敏体质患者禁用。
注意事项
1.避免与氨基糖甙类等有肾毒性药物联合使用。如果出现肾功能损伤情况,应立即停药,并给予谷胱甘肽600mg静滴,低盐饮食治疗。
2.老年人、儿童、孕妇、哺乳期妇女以及有肾脏疾患者慎用。
3.本品不宜与其他药物在同一容器中混用。
贮藏
密闭，防潮。
规格
每支装10ml
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.